Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2017

Commitments and Contingencies [Abstract]

Current Contractual Obligations

CytRx's current contractual obligations that will require future cash payments are as follows (in thousands):

	Operating Leases (1)		Employment Agreements (2)		Research and Development (3)		Total
2018	$	373	$	1,678	$	1,000	$	3,051
2019		278		1,057		—		1,335
2020		59		1,057		—		1,116
2021		—		1,057		—		1,057
2022		—		—		—		—
Thereafter		—		—		—		—
Total	$	710	$	4,849	$	1,000	$	6,559

____________

(1) Operating leases are primarily facility lease related obligations, as well as equipment lease obligations with third party vendors. The Company recognized rent expenses of $420,106, $358,247, and $351,075 in 2017, 2016 and 2015, respectively.

(2) Employment agreements include management contracts which have been revised from time to time. The employment agreement for the Company's executive officers provide for minimum salaries, which are adjusted annually at the discretion of the Company's Compensation Committee, and in some cases provide for minimum annual bonuses and employee benefits, as well.  New employment agreements for the Company's other executive officers are usually entered into annually or biennially.

(3) Research and development obligations relate primarily to the Reimbursement Agreement with NantCell. All of these purchase obligations are cancelable.